A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening

Journal of the National Cancer Institute

Volumn 96, Issue 10, 2004, Pages 770-780

  Church, Timothy R ^a   Yeazel, Mark W ^c   Jones, Resa M ^a,b   Kochevar, Laura K ^a   Watt, Gavin D ^a   Mongin, Steven J ^a   Cordes, Jill E ^a   Engelhard, Deborah ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AWARENESS; CANCER SCREENING; CLINICAL TRIAL; COLONOSCOPY; COLORECTAL CANCER; COMMUNITY CARE; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA BASE; DIAGNOSTIC KIT; FEMALE; FOLLOW UP; HEALTH PROMOTION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD TEST; OUTCOMES RESEARCH; PATIENT COMPLIANCE; POPULATION RESEARCH; POSTAL MAIL; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; SIGMOIDOSCOPY; TELEPHONE; UNITED STATES; ANALYTICAL EQUIPMENT; COLORECTAL TUMOR; FECES; MASS SCREENING; METHODOLOGY; MIDDLE AGED; OCCULT BLOOD; OUTCOME ASSESSMENT; STATISTICS;

BARIUM SULFATE; DIAGNOSTIC AGENT; ENEMA;

AGED; BARIUM SULFATE; COLONOSCOPY; COLORECTAL NEOPLASMS; ENEMA; FECES; FEMALE; GUIDELINE ADHERENCE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; MINNESOTA; OCCULT BLOOD; OUTCOME ASSESSMENT (HEALTH CARE); POSTAL SERVICE; QUESTIONNAIRES; REAGENT KITS, DIAGNOSTIC; RESEARCH DESIGN;

EID: 2942668072     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/djh134     Document Type: Article

References (48)

1. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993;328:1365-71.
2. Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472-7.
3. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;348:1467-71.
4. Winawer SJ, Flehinger BJ, Schottenfeld D, Miller DG. Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy. J Natl Cancer Inst 1993;85:1311-8.
5. Selby JV, Friedman GD, Quesenberry CP Jr, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992;326:653-7.
6. Selby JV, Friedman GD, Quesenberry CP Jr, Weiss NS. Effect of fecal occult blood testing on mortality from colorectal cancer. A case-control study. Ann Intern Med 1993;118:1-6.
7. Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 1992;84:1572-5.
8. Newcomb PA, Storer BE, Morimoto LM, Templeton A, Potter JD. Long-term efficacy of sigmoidoscopy in the reduction of colorectal cancer incidence. J Natl Cancer Inst 2003;95:622-5.
9. Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000;343:1603-7.
10. Jemal A, Thomas A, Murray T, Thun M. Cancer statistics, 2002. CA Cancer J Clin 2002;52:23-47.
11. Bond JH. Screening guidelines for colorectal cancer. Am J Med 1999;106: 7S-10S.
12. Byers T, Levin B, Rothenberger D, Dodd GD, Smith RA. American Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer: update 1997. American Cancer Society Detection and Treatment Advisory Group on Colorectal Cancer. CA Cancer J Clin 1997;47:154-60.
13. Rex DK. Colorectal cancer screening: a guide to the guidelines. Can J Gastroenterol 1999;13:397-402.
14. Winawer SJ, Fletcher RH, Miller L, Godlee F, Stolar MH, Mulrow CD, et al. Colorectal cancer screening: clinical guidelines and rationale [published errata appear in Gastroenterology 1997 Mar;112(3):1060 and 1998 Mar; 114(3):625]. Gastroenterology 1997;112:594-642.
15. Levin B, Bond JH. Colorectal cancer screening: recommendations of the U.S. Preventive Services Task Force. American Gastroenterological Association. Gastroenterology 1996;111:1381-4.
16. Holtzman D, Powell-Griner E, Bolen JC, Rhodes L. State- and sex-specific prevalence of selected characteristics - Behavioral Risk Factor Surveillance System, 1996 and 1997. MMWR CDC Surveill Summ 2000;49(6): 1-39.
17. Breen N, Wagener DK, Brown ML, Davis WW, Ballard-Barbash R. Progress in cancer screening over a decade: results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys. J Natl Cancer Inst 2001;93:1704-13.
18. Trends in screening for colorectal cancer - United States, 1997 and 1999. MMWR Morb Mortal Wkly Rep 2001;50:162-6.
19. Mandelson MT, LaCroix AZ, Anderson LA, Nadel MR, Lee NC. Comparison of self-reported fecal occult blood testing with automated laboratory records among older women in a health maintenance organization. Am J Epidemiol 1999;150:617-21.
20. Tilley BC, Vernon SW, Glanz K, Myers R, Sanders K, Lu M, et al. Worksite cancer screening and nutrition intervention for high-risk auto workers - design and baseline findings of the next step trial. Prev Med 1997;26:227-35.
21. Erban S, Zapka J, Puleo E, Vickers-Lahti M. Colorectal cancer screening in Massachusetts: measuring compliance with current guidelines. Eff Clin Pract 2001;4:10-7.
22. Minnesota Center for Health Statistics, Minnesota Department of Health. 1999 Minnesota County Demographics. Available at: http://www.lmic.state.mn.us/datanetweb/php/census2000/ PopReport.php?year=2000&final=1&area=C&subtop=P02& cnty=86&cntyname=. [Last accessed: January 9, 2004.]
23. Office of Highway Policy Information, Federal Highway Administration. Licensed drivers by sex and ratio to population - 1997. Available at: http://www.fhwa.dot.gov/ohim/hs97/dl1c.pdf. [Last accessed: March 9, 2004.]
24. Baier M, Calonge N, Cutter G, McClatchey M, Schoentgen S, Hines S, et al. Validity of self-reported colorectal cancer screening behavior. Cancer Epidemiol Biomarkers Prev 2000;9:229-32.
25. Horvitz D, Thompson D. A generalization of sampling without replacement from a finite universe. J Am Stat Assoc 1952;47:663-85.
26. Mongin S. Adjustment for non-response in the Minnesota nurses study. University of Minnesota Health Studies Section technical report. Available at: http://www1.umn.edu/eoh/NewFiles/researchpdffiles/ response.adjustment.1.pdf. [Last accessed: January 9, 2004.]
27. Efron B, Tibshirani RJ. An introduction to the bootstrap. Vol 57. New York (NY): Chapman & Hall; 1993.
28. Bejes C, Marvel MK. Attempting the improbable: offering colorectal cancer screening to all appropriate patients. Fam Pract Res J 1992;12:83-90.
29. Hardcastle JD, Armitage NC, Chamberlain J, Amar SS, James PD, Balfour TW. Fecal occult blood screening for colorectal cancer in the general population. Results of a controlled trial. Cancer 1986;58:397-403.
30. Mant D, Fuller A, Northover J, Astrop P, Chivers A, Crockett A, et al. Patient compliance with colorectal cancer screening in general practice. Br J Gen Pract 1992;42:18-20.
31. Myers RE, Ross EA, Wolf TA, Balshem A, Jepson C, Millner L. Behavioral interventions to increase adherence in colorectal cancer screening. Med Care 1991;29:1039-50.
32. Myers RE, Ross E, Jepson C, Wolf T, Balshem A, Millner L, et al. Modeling adherence to colorectal cancer screening [published erratum appears in Prev Med 1994 Jul;23(4):545]. Prev Med 1994;23:142-51.
33. Nichols S, Koch E, Lallemand R, Heald R, Izzard L, Machin D, et al. Randomised trial of compliance with screening for colorectal cancer. BMJ 1986;293:107-10.
34. Pye G, Christie M, Chamberlain J, Moss S, Hardcastle J. A comparison of methods for increasing compliance within a general practitioner based screening project for colorectal cancer and the effect on practitioner work-load. J Epidemiol Comm Health 1988;42:66-71.
35. Sontag S, Durczak C, Aranha G, Chejfec G, Frederick W, Greenlee H Fecal occult blood screening for colorectal cancer in a Veterans Administration Hospital. Am J Surg 1983;145:89-94.
36. Struewing J, Pape D, Snow D. Improving colorectal cancer screening in a medical residents' primary care clinic. Am J Prev Med 1991;7:75-81.
37. Thompson NJ, Boyko EJ, Dominitz JA, Belcher DW, Chesebro BB, Stephens LM, et al. A randomized controlled trial of a clinic-based support staff intervention to increase the rate of fecal occult blood test ordering Prev Med 2000;30:244-51.
38. Kelly R, Shank J. Adherence to screening flexible sigmoidoscopy in asymptomatic patients. Med Care 1992;30:1029-42.
39. Lee F. Screening for colorectal cancer in a factory-based population with Fecatest. Br J Cancer 1983;48:843-7.
40. Lee C. A randomized controlled trial to motivate worksite fecal occult blood testing. Yonsei Med J 1991;32:131-8.
41. Weinrich SP, Weinrich MC, Stromborg MF, Boyd MD, Weiss HL. Using elderly educators to increase colorectal cancer screening. Gerontologist 1993;33:491-6.
42. Faivre J, Arveux P, Milan C, Durand G, Lamour J, Bedenne L. Participation in mass screening for colorectal cancer: results of screening and rescreening from the Burgundy study. Eur J Cancer Prev 1991;1:49-55.
43. Herbert C, Launoy G, Thezee Y, Maurel J, Richir B, Reaud JM, et al. Participants' characteristics in a French colorectal cancer mass screening campaign. Prev Med 1995;24:498-502.
44. Tazi M, Faivre J, Dassonville F, Lamour J, Milan C, Durand G. Participation in faecal occult blood screening for colorectal cancer in a well defined French population: results of five screening rounds from 1988 to 1996. J Med Screen 1997;4:147-51.
45. Vernon SW. Participation in colorectal cancer screening - a review. J Natl Cancer Inst 1997;89:1406-22.
46. King J, Fairbrother G, Thompson C, Morris DL. Colorectal cancer screening: optimal compliance with postal faecal occult blood test. Aust N Z J Surg 1992;62:714-9.
47. Elwood T, Erickson A, Lieberman S. Comparative educational approaches to screening for colorectal cancer. Am J Public Health 1978; 68:135-8.
48. Slater P, Fich A, Zimmerman J, Ever-Hadani P, Rachmilewitz D. Recruitment of subjects for fecal occult blood screening: a comparison of two methods in Jerusalem. J Clin Gastroenterol 1985;7:51-4.